What is the current valuation of the Japan Morphine Market?

As of 2024, the Japan Morphine Market was valued at 0.648 USD Billion. Read More

What is the projected market size for the Japan Morphine Market by 2035?

The market is projected to reach 1.29 USD Billion by 2035. Read More

What is the expected CAGR for the Japan Morphine Market during the forecast period?

The expected CAGR for the Japan Morphine Market from 2025 to 2035 is 6.5%. Read More

What are the main applications of morphine in the Japanese market?

The main applications include Pain Management, Anesthesia, Palliative Care, and Cough Suppression. Read More

How does the Pain Management segment perform in terms of market valuation?

The Pain Management segment was valued at 0.325 USD Billion in 2024 and is expected to reach 0.65 USD Billion. Read More

What is the market valuation for the Anesthesia segment?

The Anesthesia segment was valued at 0.175 USD Billion in 2024 and is projected to grow to 0.35 USD Billion. Read More

What distribution channels are utilized in the Japan Morphine Market?

Distribution channels include Retail Pharmacies, Online Pharmacies, Hospital Pharmacies, and Wholesalers. Read More

What is the expected growth for the Injectable formulation type?

The Injectable formulation type was valued at 0.2 USD Billion in 2024 and is anticipated to reach 0.4 USD Billion. Read More

How does the Home Care segment compare to other end-use segments?

The Home Care segment was valued at 0.075 USD Billion in 2024 and is expected to grow to 0.15 USD Billion. Read More

Japan Morphine Market

Q: Which companies are the key players in the Japan Morphine Market?

Key players include Mitsubishi Tanabe Pharma Corporation, Takeda Pharmaceutical Company Limited, and Astellas Pharma Inc. Read More

ID: MRFR/HC/49740-HCR

200 Pages

Vikita Thakur

Last Updated: March 30, 2026

Japan Morphine Market Research Report: By Dosage Form (Injection, Oral, Other Dosage Forms), By Application (Pain Management, Diarrhea Suppressant, Cold & Cough Suppressant, Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Others) andBy End User (Hospitals & Clinics, Ambulatory Surgical Centers, Others)- Forecast to 2035

Japan Morphine Market

Market Size

Forecast Period2025 - 2035

CAGR (2025 - 2035)6.5%

2024 Market Size$ 0.65 Billion

2025 Market Size$ 0.69 Billion

2035 Market Size$ 1.29 Billion

Key Players

Mitsubishi Tanabe Pharma Corporation

Takeda Pharmaceutical Company Limited

Astellas Pharma Inc.

Daiichi Sankyo Company Limited

Ono Pharmaceutical Co.

Ltd.

Trends

Regulatory Landscape
Advancements in Drug Delivery
Shift in Pain Management Practices

Opportunities

Aging Population
Increasing Cancer Incidence
Government Policies and Regulations

Summary Table of Contents Segmentation Download PDF

Certified Researchers

Customize Report

1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
1. 1.1 EXECUTIVE SUMMARY
  1. 1.1.1 Market Overview
  2. 1.1.2 Key Findings
  3. 1.1.3 Market Segmentation
  4. 1.1.4 Competitive Landscape
  5. 1.1.5 Challenges and Opportunities
  6. 1.1.6 Future Outlook
2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
1. 2.1 MARKET INTRODUCTION
  1. 2.1.1 Definition
  2. 2.1.2 Scope of the study
    1. 2.1.2.1 Research Objective
    2. 2.1.2.2 Assumption
    3. 2.1.2.3 Limitations
2. 2.2 RESEARCH METHODOLOGY
  1. 2.2.1 Overview
  2. 2.2.2 Data Mining
  3. 2.2.3 Secondary Research
  4. 2.2.4 Primary Research
    1. 2.2.4.1 Primary Interviews and Information Gathering Process
    2. 2.2.4.2 Breakdown of Primary Respondents
  5. 2.2.5 Forecasting Model
  6. 2.2.6 Market Size Estimation
    1. 2.2.6.1 Bottom-Up Approach
    2. 2.2.6.2 Top-Down Approach
  7. 2.2.7 Data Triangulation
  8. 2.2.8 Validation
3 SECTION III: QUALITATIVE ANALYSIS
1. 3.1 MARKET DYNAMICS
  1. 3.1.1 Overview
  2. 3.1.2 Drivers
  3. 3.1.3 Restraints
  4. 3.1.4 Opportunities
2. 3.2 MARKET FACTOR ANALYSIS
  1. 3.2.1 Value chain Analysis
  2. 3.2.2 Porter's Five Forces Analysis
    1. 3.2.2.1 Bargaining Power of Suppliers
    2. 3.2.2.2 Bargaining Power of Buyers
    3. 3.2.2.3 Threat of New Entrants
    4. 3.2.2.4 Threat of Substitutes
    5. 3.2.2.5 Intensity of Rivalry
  3. 3.2.3 COVID-19 Impact Analysis
    1. 3.2.3.1 Market Impact Analysis
    2. 3.2.3.2 Regional Impact
    3. 3.2.3.3 Opportunity and Threat Analysis
4 SECTION IV: QUANTITATIVE ANALYSIS
1. 4.1 Japan Morphine Market, BY Application (USD Billion)
  1. 4.1.1 Pain Management
  2. 4.1.2 Anesthesia
  3. 4.1.3 Palliative Care
  4. 4.1.4 Cough Suppression
2. 4.2 Japan Morphine Market, BY End Use (USD Billion)
  1. 4.2.1 Hospitals
  2. 4.2.2 Clinics
  3. 4.2.3 Home Care
  4. 4.2.4 Pharmaceuticals
3. 4.3 Japan Morphine Market, BY Formulation Type (USD Billion)
  1. 4.3.1 Injectable
  2. 4.3.2 Oral
  3. 4.3.3 Transdermal
  4. 4.3.4 Sustained Release
4. 4.4 Japan Morphine Market, BY Distribution Channel (USD Billion)
  1. 4.4.1 Retail Pharmacies
  2. 4.4.2 Online Pharmacies
  3. 4.4.3 Hospital Pharmacies
  4. 4.4.4 Wholesalers
5 SECTION V: COMPETITIVE ANALYSIS
1. 5.1 Competitive Landscape
  1. 5.1.1 Overview
  2. 5.1.2 Competitive Analysis
  3. 5.1.3 Market share Analysis
  4. 5.1.4 Major Growth Strategy in the Japan Morphine Market
  5. 5.1.5 Competitive Benchmarking
  6. 5.1.6 Leading Players in Terms of Number of Developments in the Japan Morphine Market
  7. 5.1.7 Key developments and growth strategies
    1. 5.1.7.1 New Product Launch/Service Deployment
    2. 5.1.7.2 Merger & Acquisitions
    3. 5.1.7.3 Joint Ventures
  8. 5.1.8 Major Players Financial Matrix
    1. 5.1.8.1 Sales and Operating Income
    2. 5.1.8.2 Major Players R&D Expenditure. 2023
2. 5.2 Company Profiles
  1. 5.2.1 Mitsubishi Tanabe Pharma Corporation (JP)
    1. 5.2.1.1 Financial Overview
    2. 5.2.1.2 Products Offered
    3. 5.2.1.3 Key Developments
    4. 5.2.1.4 SWOT Analysis
    5. 5.2.1.5 Key Strategies
  2. 5.2.2 Takeda Pharmaceutical Company Limited (JP)
    1. 5.2.2.1 Financial Overview
    2. 5.2.2.2 Products Offered
    3. 5.2.2.3 Key Developments
    4. 5.2.2.4 SWOT Analysis
    5. 5.2.2.5 Key Strategies
  3. 5.2.3 Astellas Pharma Inc. (JP)
    1. 5.2.3.1 Financial Overview
    2. 5.2.3.2 Products Offered
    3. 5.2.3.3 Key Developments
    4. 5.2.3.4 SWOT Analysis
    5. 5.2.3.5 Key Strategies
  4. 5.2.4 Daiichi Sankyo Company Limited (JP)
    1. 5.2.4.1 Financial Overview
    2. 5.2.4.2 Products Offered
    3. 5.2.4.3 Key Developments
    4. 5.2.4.4 SWOT Analysis
    5. 5.2.4.5 Key Strategies
  5. 5.2.5 Ono Pharmaceutical Co., Ltd. (JP)
    1. 5.2.5.1 Financial Overview
    2. 5.2.5.2 Products Offered
    3. 5.2.5.3 Key Developments
    4. 5.2.5.4 SWOT Analysis
    5. 5.2.5.5 Key Strategies
  6. 5.2.6 Eisai Co., Ltd. (JP)
    1. 5.2.6.1 Financial Overview
    2. 5.2.6.2 Products Offered
    3. 5.2.6.3 Key Developments
    4. 5.2.6.4 SWOT Analysis
    5. 5.2.6.5 Key Strategies
  7. 5.2.7 Chugai Pharmaceutical Co., Ltd. (JP)
    1. 5.2.7.1 Financial Overview
    2. 5.2.7.2 Products Offered
    3. 5.2.7.3 Key Developments
    4. 5.2.7.4 SWOT Analysis
    5. 5.2.7.5 Key Strategies
  8. 5.2.8 Kyowa Kirin Co., Ltd. (JP)
    1. 5.2.8.1 Financial Overview
    2. 5.2.8.2 Products Offered
    3. 5.2.8.3 Key Developments
    4. 5.2.8.4 SWOT Analysis
    5. 5.2.8.5 Key Strategies
3. 5.3 Appendix
  1. 5.3.1 References
  2. 5.3.2 Related Reports
6 LIST OF FIGURES
1. 6.1 MARKET SYNOPSIS
2. 6.2 JAPAN MARKET ANALYSIS BY APPLICATION
3. 6.3 JAPAN MARKET ANALYSIS BY END USE
4. 6.4 JAPAN MARKET ANALYSIS BY FORMULATION TYPE
5. 6.5 JAPAN MARKET ANALYSIS BY DISTRIBUTION CHANNEL
6. 6.6 KEY BUYING CRITERIA OF JAPAN MORPHINE MARKET
7. 6.7 RESEARCH PROCESS OF MRFR
8. 6.8 DRO ANALYSIS OF JAPAN MORPHINE MARKET
9. 6.9 DRIVERS IMPACT ANALYSIS: JAPAN MORPHINE MARKET
10. 6.10 RESTRAINTS IMPACT ANALYSIS: JAPAN MORPHINE MARKET
11. 6.11 SUPPLY / VALUE CHAIN: JAPAN MORPHINE MARKET
12. 6.12 JAPAN MORPHINE MARKET, BY APPLICATION, 2024 (% SHARE)
13. 6.13 JAPAN MORPHINE MARKET, BY APPLICATION, 2024 TO 2035 (USD Billion)
14. 6.14 JAPAN MORPHINE MARKET, BY END USE, 2024 (% SHARE)
15. 6.15 JAPAN MORPHINE MARKET, BY END USE, 2024 TO 2035 (USD Billion)
16. 6.16 JAPAN MORPHINE MARKET, BY FORMULATION TYPE, 2024 (% SHARE)
17. 6.17 JAPAN MORPHINE MARKET, BY FORMULATION TYPE, 2024 TO 2035 (USD Billion)
18. 6.18 JAPAN MORPHINE MARKET, BY DISTRIBUTION CHANNEL, 2024 (% SHARE)
19. 6.19 JAPAN MORPHINE MARKET, BY DISTRIBUTION CHANNEL, 2024 TO 2035 (USD Billion)
20. 6.20 BENCHMARKING OF MAJOR COMPETITORS
7 LIST OF TABLES
1. 7.1 LIST OF ASSUMPTIONS
7.1.1
1. 7.2 Japan MARKET SIZE ESTIMATES; FORECAST
  1. 7.2.1 BY APPLICATION, 2026-2035 (USD Billion)
  2. 7.2.2 BY END USE, 2026-2035 (USD Billion)
  3. 7.2.3 BY FORMULATION TYPE, 2026-2035 (USD Billion)
  4. 7.2.4 BY DISTRIBUTION CHANNEL, 2026-2035 (USD Billion)
2. 7.3 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
7.3.1
1. 7.4 ACQUISITION/PARTNERSHIP
7.4.1

Certified Researchers

Customize Report

Japan Morphine Market Segmentation

Japan Morphine Market By Application (USD Billion, 2022-2035)

Pain Management
Anesthesia
Palliative Care
Cough Suppression

Japan Morphine Market By End Use (USD Billion, 2022-2035)

Hospitals
Clinics
Home Care
Pharmaceuticals

Japan Morphine Market By Formulation Type (USD Billion, 2022-2035)

Injectable
Oral
Transdermal
Sustained Release

Japan Morphine Market By Distribution Channel (USD Billion, 2022-2035)

Retail Pharmacies
Online Pharmacies
Hospital Pharmacies
Wholesalers

Customer Stories

“This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job”

Noah Malgeri Co-Founder

“Thanks. It’s been a pleasure working with you, please use me as reference with any other Intel employees.”

Joseph Aguayo Sales Operations & Pricing Manager

“Thanks for sending the report it gives us a good global view of the Betaïne market.”

Peter Groot koerkamp Account and Business Manager

“Thank you, this will be very helpful for OQS.”

La Terria Dodd Program Support Specialist

“We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.”

Younghwan Choi Senior Retail Manager

“I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

Mark Irwin Management Consultant

“I have been reading the first document or the study, ,the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!”